Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
Molecular Weight: 338
890190-22-4
As with recombinant cell systems
4SC-202 was dosed to A549 NSCLC xenograft model and RKO27 colon carcinoma xenografts model orally at 120 mg/Kg once per day
It inhibits LSD1 in biochemical assay with an IC50 ~16 nM
Canertinib HCl - CAS# 289499-45-2 60273 Molecular Weight: 338Canertinib, also known as CI1033 and PD183805, CAS No. 289499 45 2, is a potent ErbB inhibitor for the treatment of cancer. It is an irreversible tyrosine kinase inhibitor with activity against EGFR (IC50 0. 8 nM), HER 2 (IC50 19 nM) and ErbB 4 (IC50 7 nM). By 2015, Pfizer had discontinued development of the drug. Canertinib has been reported as a substrate for OATP1B3. Interaction of canertinib with OATP1B3 may alter its hepatic disposition and can
US$ 2250.00
US$ 178.20
US$ 284.18
US$ 147.50
US$ 83.70
US$ 309.15
US$ 953.10
US$ 145.00